首页> Clinical and experimental nephrology> A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).

A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).

导出 LinkOut

翻译打印收藏纠错

第一作者： Toshiaki,Shibasaki

第一单位： Department of Pharmacotherapeutics, Kyoritsu College of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan. shibasaki-ts@kyoritsu.ph.ac.jp

作者： Toshiaki,Shibasaki ^[1] ; Akio,Koyama ; Akira,Hishida ; Eri,Muso ; Gengo,Osawa ; Hideaki,Yamabe ; Hideo,Shiiki ; Hirofumi,Makino ; Hiroshi,Sato ; Isao,Ishikawa ; Kenji,Maeda ; Kimio,Tomita ; Masaaki,Arakawa ; Masashi,Ishida ; Masashi,Sato ; Mitsumasa,Nagase ; Naoki,Kashihara ; Noriaki,Yorioka ; Takao,Koike ; Takao,Saito ; Takashi,Harada ; Tetsuya,Mitarai ; Tetsuzo,Sugisaki ; Toshihiko,Nagasawa ; Yasuhiko,Tomino ; Yoshihisa,Nojima ; Yutaka,Kobayashi ; Osamu,Sakai

作者单位： Department of Pharmacotherapeutics, Kyoritsu College of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan. shibasaki-ts@kyoritsu.ph.ac.jp ^[1]